Targeting the neural extracellular matrix in neurological disorders

Neuroscience

Volumn 253, Issue , 2013, Pages 194-213

  Soleman, S ^a   Filippov, M A ^b,c   Dityatev, A ^b,c,d   Fawcett, J W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Epilepsy; Extracellular matrix; Perineuronal nets; Plasticity; Proteoglycans; Spinal cord injury

Indexed keywords

CHONDROITIN ABC LYASE; CORE PROTEIN; HYALURONIC ACID; LINK PROTEIN; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; SEMAPHORIN; TRANSCRIPTION FACTOR OTX2;

ALZHEIMER DISEASE; AMBLYOPIA; CELL MIGRATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; ENZYME DEGRADATION; EPILEPSY; EPILEPTOGENESIS; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MICROENVIRONMENT; MULTIINFARCT DEMENTIA; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PERINEURONAL NET; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; SYNAPTOGENESIS; TRAUMATIC BRAIN INJURY;

AD; ADDLS; ALZHEIMER'S DISEASE; AMYLOID-DERIVED DIFFUSIBLE LIGANDS; BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHABC; CHONDROITIN SULFATE PROTEOGLYCANS; CHONDROITINASE ABC; CSPGS; ECM; EPILEPSY; EXTRACELLULAR MATRIX; GAG; GLYCOSAMINOGLYCAN; HEPARAN SULFATE PROTEOGLYCANS; HSPGS; LEUCINE-RICH, GLIOMA-INACTIVATED 1; LGI1; LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LONG-TERM DEPRESSION; LONG-TERM POTENTIATION; LRP1; LTD; LTP; MATRIX METALLOPROTEINASE; MEPSCS; MINIATURE EXCITATORY POSTSYNAPTIC CURRENTS; MMP; OLIGODENDROCYTE PRECURSOR CELLS; OPCS; ORTHODENTICLE HOMEOBOX PROTEIN 2; OTX2; PARVALBUMIN; PERINEURONAL NETS; PLASTICITY; PNNS; PROTEOGLYCANS; PV; SCI; SPINAL CORD INJURY; SRPX2; SUSHI-REPEAT PROTEIN, X-LINKED 2; UPA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

ANIMALS; CHONDROITIN SULFATE PROTEOGLYCANS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; NERVOUS SYSTEM DISEASES; NEURONS;

EID: 84884572454     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.050     Document Type: Review

References (238)

1. Alilain W.J., Horn K.P., Hu H., Dick T.E., Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011, 475:196-200.
2. Allen N.J., Bennett M.L., Foo L.C., Wang G.X., Chakraborty C., Smith S.J., Barres B.A. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 2012, 486:410-414.
3. Asahina M., Yoshiyama Y., Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol 2001, 20:60-63.
4. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000, 20:2427-2438.
5. Asher R.A., Morgenstern D.A., Moon L.D., Fawcett J.W. Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res 2001, 132:611-619.
6. Asher R.A., Morgenstern D.A., Shearer M.C., Adcock K.H., Pesheva P., Fawcett J.W. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 2002, 22:2225-2236.
7. Backstrom J.R., Lim G.P., Cullen M.J., Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 1996, 16:7910-7919.
8. Badan I., Buchhold B., Hamm A., Gratz M., Walker L.C., Platt D., Kessler C., Popa-Wagner A. Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab 2003, 23:845-854.
9. Baig S., Wilcock G.K., Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol 2005, 110:393-401.
10. Bandtlow C.E., Zimmermann D.R. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000, 80:1267-1290.
11. Benilova I., Karran E., De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012, 15:349-357.
12. Berardi N., Pizzorusso T., Maffei L. Extracellular matrix and visual cortical plasticity: freeing the synapse. Neuron 2004, 44:905-908.
13. Berardi N., Pizzorusso T., Ratto G.M., Maffei L. Molecular basis of plasticity in the visual cortex. Trends Neurosci 2003, 26:369-378.
14. Beurdeley M., Spatazza J., Lee H.H., Sugiyama S., Bernard C., Di Nardo A.A., Hensch T.K., Prochiantz A. Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual cortex. J Neurosci 2012, 32:9429-9437.
15. Biernaskie J., Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci 2001, 21:5272-5280.
16. Biroc S.L., Payan D.G., Fisher J.M. Isoforms of agrin are widely expressed in the developing rat and may function as protease inhibitors. Brain Res Dev Brain Res 1993, 75:119-129.
17. Boggio E.M., Ehlert E.M.E., Moloney E.M., Mecollari V., Fawcett J.W., Verhaagen J., Pizzorusso T. AAV-mediated expression of neuropilin1-Fc, a secreted receptor that inactivates semaphorin3a, enhances ocular dominance plasticity in the adult rat visual cortex 2012, 8th FENS Forum of Neuroscience, Barcelona.
18. Bouzioukh F., Daoudal G., Falk J., Debanne D., Rougon G., Castellani V. Semaphorin3A regulates synaptic function of differentiated hippocampal neurons. Eur J Neurosci 2006, 23:2247-2254.
19. Bovolenta P., Wandosell F., Nieto-Sampedro M. Neurite outgrowth inhibitors associated with glial cells and glial cell lines. Neuroreport 1993, 5:345-348.
20. Bowes C., Massey J.M., Burish M., Cerkevich C.M., Kaas J.H. Chondroitinase ABC promotes selective reactivation of somatosensory cortex in squirrel monkeys after a cervical dorsal column lesion. Proc Natl Acad Sci USA 2012, 109:2595-2600.
21. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2010, 84:306-316.
22. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
23. Brakebusch C., Seidenbecher C.I., Asztely F., Rauch U., Matthies H., Meyer H., Krug M., Bockers T.M., Zhou X., Kreutz M.R., Montag D., Gundelfinger E.D., Fassler R. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol 2002, 22:7417-7427.
24. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998, 88:1337-1342.
25. Bruckner G., Brauer K., Hartig W., Wolff J.R., Rickmann M.J., Derouiche A., Delpech B., Girard N., Oertel W.H., Reichenbach A. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 1993, 8:183-200.
26. Bruckner G., Grosche J., Schmidt S., Hartig W., Margolis R.U., Delpech B., Seidenbecher C.I., Czaniera R., Schachner M. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol 2000, 428:616-629.
27. Bruckner G., Hausen D., Hartig W., Drlicek M., Arendt T., Brauer K. Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer's disease. Neuroscience 1999, 92:791-805.
28. Bruno M.A., Mufson E.J., Wuu J., Cuello A.C. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 2009, 68:1309-1318.
29. Bukalo O., Schachner M., Dityatev A. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 2001, 104:359-369.
30. Bukalo O., Schachner M., Dityatev A. Hippocampal metaplasticity induced by deficiency in the extracellular matrix glycoprotein tenascin-R. J Neurosci 2007, 27:6019-6028.
31. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., Staufenbiel M., Konnerth A., Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321:1686-1689.
32. Cafferty W.B., Bradbury E.J., Lidierth M., Jones M., Duffy P.J., Pezet S., McMahon S.B. Chondroitinase ABC-mediated plasticity of spinal sensory function. J Neurosci 2008, 28:11998-12009.
33. Caggiano A.O., Zimber M.P., Ganguly A., Blight A.R., Gruskin E.A. Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 2005, 22:226-239.
34. Canas N., Valero T., Villarroya M., Montell E., Verges J., Garcia A.G., Lopez M.G. Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt. J Pharmacol Exp Ther 2007, 323:946-953.
35. Carmichael S.T. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol 2006, 59:735-742.
36. Carmichael S.T., Archibeque I., Luke L., Nolan T., Momiy J., Li S. Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol 2005, 193:291-311.
37. Carter L.M., Starkey M.L., Akrimi S.F., Davies M., McMahon S.B., Bradbury E.J. The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury. J Neurosci 2008, 28:14107-14120.
38. Carulli D., Laabs T., Geller H.M., Fawcett J.W. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 2005, 15:116-120.
39. Carulli D., Pizzorusso T., Kwok J.C., Putignano E., Poli A., Forostyak S., Andrews M.R., Deepa S.S., Glant T.T., Fawcett J.W. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
40. Carulli D., Rhodes K.E., Brown D.J., Bonnert T.P., Pollack S.J., Oliver K., Strata P., Fawcett J.W. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol 2006, 494:559-577.
41. Castillo G.M., Ngo C., Cummings J., Wight T.N., Snow A.D. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 1997, 69:2452-2465.
42. Celio M.R., Blumcke I. Perineuronal nets-a specialized form of extracellular matrix in the adult nervous system. Brain Res Brain Res Rev 1994, 19:128-145.
43. Celio M.R., Spreafico R., De B.S., Vitellaro-Zuccarello L. Perineuronal nets: past and present. Trends Neurosci 1998, 21:510-515.
44. Chau C.H., Shum D.K., Li H., Pei J., Lui Y.Y., Wirthlin L., Chan Y.S., Xu X.M. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J 2004, 18:194-196.
45. Chen Z.J., Negra M., Levine A., Ughrin Y., Levine J.M. Oligodendrocyte precursor cells: reactive cells that inhibit axon growth and regeneration. J Neurocytol 2002, 31:481-495.
46. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990, 13:171-182.
47. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., Lawler J., Mosher D.F., Bornstein P., Barres B.A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
48. Chun W., Johnson G.V. The role of tau phosphorylation and cleavage in neuronal cell death. Front Biosci 2007, 12:733-756.
49. Corvetti L., Rossi F. Degradation of chondroitin sulfate proteoglycans induces sprouting of intact purkinje axons in the cerebellum of the adult rat. J Neurosci 2005, 25:7150-7158.
50. Cotman S.L., Halfter W., Cole G.J. Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci 2000, 15:183-198.
51. Crespo D., Asher R.A., Lin R., Rhodes K.E., Fawcett J.W. How does chondroitinase promote functional recovery in the damaged CNS?. Exp Neurol 2007, 206:159-171.
52. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999, 19:5810-5822.
53. De Vivo L., Landi S., Panniello M., Baroncelli L., Chierzi S., Mariotti L., Spolidoro M., Pizzorusso T., Maffei L., Ratto G.M. Extracellular matrix inhibits structural and functional plasticity of dendritic spines in the adult visual cortex. Mol Ther 2013, 4:1484.
54. De Wit J., De Winter F., Klooster J., Verhaagen J. Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix. Mol Cell Neurosci 2005, 29:40-55.
55. Deb S., Gottschall P.E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem 1996, 66:1641-1647.
56. Deb S., Wenjun Zhang J., Gottschall P.E. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res 2003, 970:205-213.
57. Deepa S.S., Carulli D., Galtrey C., Rhodes K., Fukuda J., Mikami T., Sugahara K., Fawcett J.W. Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 2006, 281:17789-17800.
58. Dityatev A. Remodeling of extracellular matrix and epileptogenesis. Epilepsia 2010, 51(Suppl. 3):61-65.
59. Dityatev A., Bruckner G., Dityateva G., Grosche J., Kleene R., Schachner M. Activity-dependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev Neurobiol 2007, 67:570-588.
60. Dityatev A., Bukalo O., Schachner M. Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules. Neuron Glia Biol. 2008, 4:197-209.
61. Dityatev A., Fellin T. Extracellular matrix in plasticity and epileptogenesis. Neuron Glia Biol 2009, 4:235-247.
62. Dityatev A., Schachner M., Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci 2010, 11:735-746.
63. Donahue J.E., Berzin T.M., Rafii M.S., Glass D.J., Yancopoulos G.D., Fallon J.R., Stopa E.G. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci USA 1999, 96:6468-6472.
64. Dou C.L., Levine J.M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J Neurosci 1994, 14:7616-7628.
65. Eroglu C., Allen N.J., Susman M.W., O'Rourke N.A., Park C.Y., Ozkan E., Chakraborty C., Mulinyawe S.B., Annis D.S., Huberman A.D., Green E.M., Lawler J., Dolmetsch R., Garcia K.C., Smith S.J., Luo Z.D., Rosenthal A., Mosher D.F., Barres B.A. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009, 139:380-392.
66. Esiri M.M. Ageing and the brain. J Pathol 2007, 211:181-187.
67. Espinosa J.S., Stryker M.P. Development and plasticity of the primary visual cortex. Neuron 2012, 75:230-249.
68. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation - potential functions of the perisynaptic extracellular matrix. Brain Res Rev 2010, 63:26-38.
69. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004, 24:2143-2155.
70. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res Bull 1999, 49:377-391.
71. Filla M.S., Dam P., Rapraeger A.C. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J Cell Physiol 1998, 174:310-321.
72. Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.L., Bachoo R., Cannon S., Longo F.M., Sheng M., Silver J., Li S. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci 2011, 31:14051-14066.
73. Fragkouli A., Papatheodoropoulos C., Georgopoulos S., Stamatakis A., Stylianopoulou F., Tsilibary E.C., Tzinia A.K. Enhanced neuronal plasticity and elevated endogenous sAPPalpha levels in mice over-expressing MMP9. J Neurochem 2012, 121:239-251.
74. Fragkouli A., Tzinia A.K., Charalampopoulos I., Gravanis A., Tsilibary E.C. Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells. J Alzheimers Dis 2011, 24:705-719.
75. Frischknecht R., Heine M., Perrais D., Seidenbecher C.I., Choquet D., Gundelfinger E.D. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 2009, 12:897-904.
76. Frischknecht R., Seidenbecher C.I. The crosstalk of hyaluronan-based extracellular matrix and synapses. Neuron Glia Biol 2008, 4:249-257.
77. Fry E.J., Chagnon M.J., Lopez-Vales R., Tremblay M.L., David S. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010, 58:423-433.
78. Fukata Y., Lovero K.L., Iwanaga T., Watanabe A., Yokoi N., Tabuchi K., Shigemoto R., Nicoll R.A., Fukata M. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA 2010, 107:3799-3804.
79. Galtrey C.M., Asher R.A., Nothias F., Fawcett J.W. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain 2007, 130:926-939.
80. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 2007, 54:1-18.
81. Garcia-Alias G., Barkhuysen S., Buckle M., Fawcett J.W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 2009, 12:1145-1151.
82. Gasparini L., Dityatev A. Beta-amyloid and glutamate receptors. Exp Neurol 2008, 212:1-4.
83. Girgis J., Merrett D., Kirkland S., Metz G.A., Verge V., Fouad K. Reaching training in rats with spinal cord injury promotes plasticity and task specific recovery. Brain 2007, 130:2993-3003.
84. Gotting C., Kuhn J., Zahn R., Brinkmann T., Kleesiek K. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol 2000, 304:517-528.
85. Grimpe B., Pressman Y., Lupa M.D., Horn K.P., Bunge M.B., Silver J. The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci 2005, 28:18-29.
86. Grimpe B., Silver J. The extracellular matrix in axon regeneration. Prog Brain Res 2002, 137:333-349.
87. Groffen A.J., Buskens C.A., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A., van den Heuvel L.P. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. FEBS J 1998, 254:123-128.
88. Gundelfinger E.D., Frischknecht R., Choquet D., Heine M. Converting juvenile into adult plasticity: a role for the brain's extracellular matrix. Eur J Neurosci 2010, 31:2156-2165.
89. Gupta-Bansal R., Frederickson R.C., Brunden K.R. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 1995, 270:18666-18671.
90. Hardingham T.E., Fosang A.J. Proteoglycans: many forms and many functions. FASEB J 1992, 6:861-870.
91. Hartig W., Brauer K., Bigl V., Bruckner G. Chondroitin sulfate proteoglycan-immunoreactivity of lectin-labeled perineuronal nets around parvalbumin-containing neurons. Brain Res 1994, 635:307-311.
92. Hartig W., Derouiche A., Welt K., Brauer K., Grosche J., Mader M., Reichenbach A., Bruckner G. Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res 1999, 842:15-29.
93. Hartig W., Klein C., Brauer K., Schuppel K.F., Arendt T., Bigl V., Bruckner G. Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison. Neurobiol Aging 2001, 22:25-33.
94. Hensch T.K. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005, 6:877-888.
95. Hensch T.K., Fagiolini M., Mataga N., Stryker M.P., Baekkeskov S., Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998, 282:1504-1508.
96. Hill J.J., Jin K., Mao X.O., Xie L., Greenberg D.A. Intracerebral chondroitinase ABC and heparan sulfate proteoglycan glypican improve outcome from chronic stroke in rats. Proc Natl Acad Sci USA 2012, 109:9155-9160.
97. Hobohm C., Gunther A., Grosche J., Rossner S., Schneider D., Bruckner G. Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 2005, 80:539-548.
98. Hobohm C., Gunther A., Grosche J., Rossner S., Schneider D., Bruckner G. Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res 2005, 80:539-548.
99. Hobohm C., Hartig W., Brauer K., Bruckner G. Low expression of extracellular matrix components in rat brain stem regions containing modulatory aminergic neurons. J Chem Neuroanat 1998, 15:135-142.
100. Hoffmann K., Sivukhina E., Potschka H., Schachner M., Löscher W., Dityatev A. Retarded kindling progression in mice deficient in the extracellular matrix glycoprotein tenascin-R. Epilepsia 2009, 50:859-869.
101. Hsueh Y.P., Sheng M. Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J Neurosci 1999, 19:7415-7425.
102. Huang W.C., Kuo W.C., Cherng J.H., Hsu S.H., Chen P.R., Huang S.H., Huang M.C., Liu J.C., Cheng H. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 2006, 349:963-968.
103. Hubel D.H., Wiesel T.N., LeVay S. Functional architecture of area 17 in normal and monocularly deprived macaque monkeys. Cold Spring Harb Symp Quant Biol 1976, 40:581-589.
104. Hunanyan A.S., Garcia-Alias G., Alessi V., Levine J.M., Fawcett J.W., Mendell L.M., Arvanian V.L. Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord. J Neurosci 2010, 30:7761-7769.
105. Huntley G.W. Synaptic circuit remodelling by matrix metalloproteinases in health and disease. Nat Rev Neurosci 2012, 13:743-757.
106. Hyatt A.J., Wang D., Kwok J.C., Fawcett J.W., Martin K.R. Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord. J Control Release 2010, 147:24-29.
107. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005, 1739:198-210.
108. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., Peles E., Buckley C., Lang B., Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
109. Iseda T., Okuda T., Kane-Goldsmith N., Mathew M., Ahmed S., Chang Y.W., Young W., Grumet M. Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion. J Neurotrauma 2008, 25:334-349.
110. Ito S., Kimura K., Haneda M., Ishida Y., Sawada M., Isobe K. Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway. Exp Gerontol 2007, 42:532-537.
111. Ito S., Sawada M., Haneda M., Fujii S., Oh-Hashi K., Kiuchi K., Takahashi M., Isobe K. Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the PI3-kinase/Akt pathway in cultured Ra2 microglial cells. FEBS Lett 2005, 579:1995-2000.
112. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003, 182:399-411.
113. Kalb R.G., Hockfield S. Electrical activity in the neuromuscular unit can influence the molecular development of motor neurons. Dev Biol 1994, 162:539-548.
114. Kanekiyo T., Zhang J., Liu Q., Liu C.C., Zhang L., Bu G. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci 2011, 31:1644-1651.
115. Kantor D.B., Chivatakarn O., Peer K.L., Oster S.F., Inatani M., Hansen M.J., Flanagan J.G., Yamaguchi Y., Sretavan D.W., Giger R.J., Kolodkin A.L. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44:961-975.
116. Karetko-Sysa M., Skangiel-Kramska J., Nowicka D. Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death. Exp Neurol 2011, 231:113-126.
117. Karimi-Abdolrezaee S., Schut D., Wang J., Fehlings M.G. Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One 2012, 7:e37589.
118. Katsman D., Zheng J., Spinelli K., Carmichael S.T. Tissue microenvironments within functional cortical subdivisions adjacent to focal stroke. J Cereb Blood Flow Metab 2003, 23:997-1009.
119. Kim G.W., Kim H.J., Cho K.J., Kim H.W., Cho Y.J., Lee B.I. The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus. Neurobiol Dis 2009, 36:169-180.
120. Kobayashi K., Emson P.C., Mountjoy C.Q. Vicia villosa lectin-positive neurones in human cerebral cortex. Loss in Alzheimer-type dementia. Brain Res 1989, 498:170-174.
121. Komitova M., Perfilieva E., Mattsson B., Eriksson P.S., Johansson B.B. Enriched environment after focal cortical ischemia enhances the generation of astroglia and NG2 positive polydendrocytes in adult rat neocortex. Exp Neurol 2006, 199:113-121.
122. Koppe G., Bruckner G., Brauer K., Hartig W., Bigl V. Developmental patterns of proteoglycan-containing extracellular matrix in perineuronal nets and neuropil of the postnatal rat brain. Cell Tissue Res 1997, 288:33-41.
123. Koppe G., Bruckner G., Hartig W., Delpech B., Bigl V. Characterization of proteoglycan-containing perineuronal nets by enzymatic treatments of rat brain sections. Histochem J 1997, 29:11-20.
124. Ksiazek I., Burkhardt C., Lin S., Seddik R., Maj M., Bezakova G., Jucker M., Arber S., Caroni P., Sanes J.R., Bettler B., Ruegg M.A. Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. J Neurosci 2007, 27:7183-7195.
125. Kuperstein I., Broersen K., Benilova I., Rozenski J., Jonckheere W., Debulpaep M., Vandersteen A., Segers-Nolten I., Van Der Werf K., Subramaniam V., Braeken D., Callewaert G., Bartic C., D'Hooge R., Martins I.C., Rousseau F., Schymkowitz J., De Strooper B. Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J 2010, 29:3408-3420.
126. Kurihara D., Yamashita T. Chondroitin sulfate proteoglycans down-regulate spine formation in cortical neurons by targeting tropomyosin-related kinase B (TrkB) protein. J Biol Chem 2012, 287:13822-13828.
127. Kwok J.C., Afshari F., Garcia-Alias G., Fawcett J.W. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci 2008, 26:131-145.
128. Kwok J.C., Dick G., Wang D., Fawcett J.W. Extracellular matrix and perineuronal nets in CNS repair. Dev Neurobiol 2011, 71:1073-1089.
129. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Viola K.L., Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007, 27:796-807.
130. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998, 95:6448-6453.
131. Lauren J., Gimbel D.A., Nygaard H.B., Gilbert J.W., Strittmatter S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009, 457:1128-1132.
132. Lee H., McKeon R.J., Bellamkonda R.V. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci USA 2010, 107:3340-3345.
133. Lemons M.L., Howland D.R., Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol 1999, 160:51-65.
134. Leuba G., Kraftsik R., Saini K. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases. Exp Neurol 1998, 152:278-291.
135. Li R., Polat U., Makous W., Bavelier D. Enhancing the contrast sensitivity function through action video game training. Nat Neurosci 2009, 12:549-551.
136. Li W., Poteet E., Xie L., Liu R., Wen Y., Yang S.H. Regulation of matrix metalloproteinase 2 by oligomeric amyloid beta protein. Brain Res 2011, 1387:141-148.
137. Litwack E.D., Ivins J.K., Kumbasar A., Paine-Saunders S., Stipp C.S., Lander A.D. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev Dyn 1998, 211:72-87.
138. Liu T., Xu J., Chan B.P., Chew S.Y. Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res A 2012, 100:236-242.
139. Lo F.S., Zhao S., Erzurumlu R.S. Astrocytes promote peripheral nerve injury-induced reactive synaptogenesis in the neonatal CNS. J Neurophysiol 2011, 106:2876-2887.
140. Lukasiuk K., Wilczynski G.M., Kaczmarek L. Extracellular proteases in epilepsy. Epilepsy Res 2011, 96:191-206.
141. Martin-de-Saavedra M.D., del Barrio L., Canas N., Egea J., Lorrio S., Montell E., Verges J., Garcia A.G., Lopez M.G. Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFkappaB and iNOS. Neurochem Int 2011, 58:676-683.
142. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G., Silver J., Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 2008, 209:426-445.
143. Massey J.M., Hubscher C.H., Wagoner M.R., Decker J.A., Amps J., Silver J., Onifer S.M. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci 2006, 26:4406-4414.
144. Matsui F., Oohira A. Proteoglycans and injury of the central nervous system. Congenit Anom (Kyoto) 2004, 44:181-188.
145. Matsumoto H., Kumon Y., Watanabe H., Ohnishi T., Shudou M., Chuai M., Imai Y., Takahashi H., Tanaka J. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2008, 28:149-163.
146. Matthews R.T., Kelly G.M., Zerillo C.A., Gray G., Tiemeyer M., Hockfield S. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 2002, 22:7536-7547.
147. McCroskery S., Bailey A., Lin L., Daniels M.P. Transmembrane agrin regulates dendritic filopodia and synapse formation in mature hippocampal neuron cultures. Neuroscience 2009, 163:168-179.
148. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995, 136:32-43.
149. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 1999, 19:10778-10788.
150. McRae P.A., Baranov E., Rogers S.L., Porter B.E. Persistent decrease in multiple components of the perineuronal net following status epilepticus. Eur J Neurosci 2012, 36:3471-3482.
151. Meredith J.E., Fazeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961.
152. Michaluk P., Mikasova L., Groc L., Frischknecht R., Choquet D., Kaczmarek L. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling. J Neurosci 2009, 29:6007-6012.
153. Michaluk P., Wawrzyniak M., Alot P., Szczot M., Wyrembek P., Mercik K., Medvedev N., Wilczek E., De Roo M., Zuschratter W., Muller D., Wilczynski G.M., Mozrzymas J.W., Stewart M.G., Kaczmarek L., Wlodarczyk J. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. J Cell Sci 2011, 124:3369-3380.
154. Miyata S., Komatsu Y., Yoshimura Y., Taya C., Kitagawa H. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci 2012, 15:414-422.
155. Miyata S., Nishimura Y., Nakashima T. Perineuronal nets protect against amyloid beta-protein neurotoxicity in cultured cortical neurons. Brain Res 2007, 1150:200-206.
156. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 2001, 4:465-466.
157. Morawski M., Bruckner G., Jager C., Seeger G., Arendt T. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Neuroscience 2010, 169:1347-1363.
158. Morawski M., Bruckner G., Jager C., Seeger G., Matthews R.T., Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol 2012, 22:547-561.
159. Morawski M., Bruckner M.K., Riederer P., Bruckner G., Arendt T. Perineuronal nets potentially protect against oxidative stress. Exp Neurol 2004, 188:309-315.
160. Morellini F., Sivukhina E., Stoenica L., Oulianova E., Bukalo O., Jakovcevski I., Dityatev A., Irintchev A., Schachner M. Improved reversal learning and working memory and enhanced reactivity to novelty in mice with enhanced GABAergic innervation in the dentate gyrus. Cereb Cortex 2010, 20:2712-2727.
161. Morris N.P., Henderson Z. Perineuronal nets ensheath fast spiking, parvalbumin-immunoreactive neurons in the medial septum/diagonal band complex. Eur J Neurosci 2000, 12:828-838.
162. Mroczko B., Groblewska M., Barcikowska M. The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in the Pathophysiology of Neurodegeneration: A Literature Study. J Alzheimers Dis 2013, 37:273-283.
163. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 2006, 26:1923-1934.
164. Nakamae T., Tanaka N., Nakanishi K., Kamei N., Sasaki H., Hamasaki T., Yamada K., Yamamoto R., Mochizuki Y., Ochi M. Chondroitinase ABC promotes corticospinal axon growth in organotypic cocultures. Spinal Cord 2009, 47:161-165.
165. Nobile C., Michelucci R., Andreazza S., Pasini E., Tosatto S.C., Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009, 30:530-536.
166. Noguchi A., Matsumura S., Dezawa M., Tada M., Yanazawa M., Ito A., Akioka M., Kikuchi S., Sato M., Ideno S., Noda M., Fukunari A., Muramatsu S., Itokazu Y., Sato K., Takahashi H., Teplow D.B., Nabeshima Y., Kakita A., Imahori K., Hoshi M. Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem 2009, 284:32895-32905.
167. Nothias F., Fishell G., Altaba A. Cooperation of intrinsic and extrinsic signals in the elaboration of regional identity in the posterior cerebral cortex. Curr Biol 1998, 8:459-462.
168. O'Callaghan P., Sandwall E., Li J.P., Yu H., Ravid R., Guan Z.Z., van Kuppevelt T.H., Nilsson L.N., Ingelsson M., Hyman B.T., Kalimo H., Lindahl U., Lannfelt L., Zhang X. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells. Brain Pathol 2008, 18:548-561.
169. Okamoto M., Mori S., Ichimura M., Endo H. Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids. Neurosci Lett 1994, 172:51-54.
170. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., Wilczynski G.M., Sanchez-Capelo A., Mallet J., Kaczmarek L. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 2007, 62:359-362.
171. Orlando C., Ster J., Gerber U., Fawcett J.W., Raineteau O. Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner. J Neurosci 2012, 32(18009-18017):18017a.
172. Owuor K., Harel N.Y., Englot D.J., Hisama F., Blumenfeld H., Strittmatter S.M. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci 2009, 42:448-457.
173. Paradis S., Harrar D.B., Lin Y., Koon A.C., Hauser J.L., Griffith E.C., Zhu L., Brass L.F., Chen C., Greenberg M.E. An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. Neuron 2007, 53:217-232.
174. Parameshwaran K., Sims C., Kanju P., Vaithianathan T., Shonesy B.C., Dhanasekaran M., Bahr B.A., Suppiramaniam V. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse 2007, 61:367-374.
175. Parodi J., Sepulveda F.J., Roa J., Opazo C., Inestrosa N.C., Aguayo L.G. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 2010, 285:2506-2514.
176. Pasterkamp R.J., De W.F., Holtmaat A.J., Verhaagen J. Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci 1998, 18:9962-9976.
177. Pasterkamp R.J., Giger R.J. Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 2009, 19:263-274.
178. Pasterkamp R.J., Giger R.J., Ruitenberg M.J., Holtmaat A.J., De W.J., De W.F., Verhaagen J. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci 1999, 13:143-166.
179. Pasterkamp R.J., Kolodkin A.L. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003, 13:79-89.
180. Perry G., Siedlak S.L., Richey P., Kawai M., Cras P., Kalaria R.N., Galloway P.G., Scardina J.M., Cordell B., Greenberg B.D., et al. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci 1991, 11:3679-3683.
181. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
182. Pizzorusso T., Medini P., Landi S., Baldini S., Berardi N., Maffei L. Structural and functional recovery from early monocular deprivation in adult rats. Proc Natl Acad Sci USA 2006, 103:8517-8522.
183. Pye D.A., Vives R.R., Turnbull J.E., Hyde P., Gallagher J.T. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 1998, 273:22936-22942.
184. Pyka M., Wetzel C., Aguado A., Geissler M., Hatt H., Faissner A. Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons. Eur J Neurosci 2011, 33:2187-2202.
185. Ramon y Cajal S. Degeneration and regeneration of the nervous system 1928, Oxford University Press, London.
186. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8:205-216.
187. Rothwell P.M., Coull A.J., Silver L.E., Fairhead J.F., Giles M.F., Lovelock C.E., Redgrave J.N., Bull L.M., Welch S.J., Cuthbertson F.C., Binney L.E., Gutnikov S.A., Anslow P., Banning A.P., Mant D., Mehta Z. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005, 366:1773-1783.
188. Royer-Zemmour B., Ponsole-Lenfant M., Gara H., Roll P., Leveque C., Massacrier A., Ferracci G., Cillario J., Robaglia-Schlupp A., Vincentelli R., Cau P., Szepetowski P. Epileptic and developmental disorders of the speech cortex: ligand/receptor interaction of wild-type and mutant SRPX2 with the plasminogen activator receptor uPAR. Hum Mol Genet 2008, 17:3617-3630.
189. Sagane K., Hayakawa K., Kai J., Hirohashi T., Takahashi E., Miyamoto N., Ino M., Oki T., Yamazaki K., Nagasu T. Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci 2005, 6:33.
190. Sahay A., Kim C.H., Sepkuty J.P., Cho E., Huganir R.L., Ginty D.D., Kolodkin A.L. Secreted semaphorins modulate synaptic transmission in the adult hippocampus. J Neurosci 2005, 25:3613-3620.
191. Sale A., Maya Vetencourt J.F., Medini P., Cenni M.C., Baroncelli L., De P.R., Maffei L. Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition. Nat Neurosci 2007, 10:679-681.
192. Schulte U., Thumfart J.O., Klocker N., Sailer C.A., Bildl W., Biniossek M., Dehn D., Deller T., Eble S., Abbass K., Wangler T., Knaus H.G., Fakler B. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006, 49:697-706.
193. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008, 14:837-842.
194. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
195. Silingardi D., Angelucci A., De P.R., Borsotti M., Squitieri G., Brambilla R., Putignano E., Pizzorusso T., Berardi N. ERK pathway activation bidirectionally affects visual recognition memory and synaptic plasticity in the perirhinal cortex. Front Behav Neurosci 2011, 5:84.
196. Smith-Thomas L.C., Fok-Seang J., Stevens J., Du J.S., Muir E., Faissner A., Geller H.M., Rogers J.H., Fawcett J.W. An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci 1994, 107(Pt 6):1687-1695.
197. Smith-Thomas L.C., Stevens J., Fok-Seang J., Faissner A., Rogers J.H., Fawcett J.W. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci 1995, 108(Pt 3):1307-1315.
198. Snow A.D., Kinsella M.G., Parks E., Sekiguchi R.T., Miller J.D., Kimata K., Wight T.N. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 1995, 320:84-95.
199. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988, 133:456-463.
200. Snow A.D., Mar H., Nochlin D., Sekiguchi R.T., Kimata K., Koike Y., Wight T.N. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990, 137:1253-1270.
201. Snow A.D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W.A., Morgan D.G. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 1994, 12:219-234.
202. Snow A.D., Sekiguchi R.T., Nochlin D., Kalaria R.N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994, 144:337-347.
203. Snow A.D., Wight T.N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging 1989, 10:481-497.
204. Snow D.M., Lemmon V., Carrino D.A., Caplan A.I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 1990, 109:111-130.
205. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
206. Soleman S., Yip P.K., Duricki D.A., Moon L.D. Delayed treatment with chondroitinase ABC promotes sensorimotor recovery and plasticity after stroke in aged rats. Brain 2012, 135:1210-1223.
207. Southwell D.G., Froemke R.C., Alvarez-Buylla A., Stryker M.P., Gandhi S.P. Cortical plasticity induced by inhibitory neuron transplantation. Science 2010, 327:1145-1148.
208. Spatazza J., Di L.E., Joliot A., Dupont E., Moya K.L., Prochiantz A. Homeoprotein signaling in development, health, and disease: a shaking of dogmas offers challenges and promises from bench to bed. Pharmacol Rev 2013, 65:90-104.
209. Spicer A.P., Joo A., Bowling R.A. A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core protein genes: the missing links. J Biol Chem 2003, 278:21083-21091.
210. Sugiyama S., Di Nardo A.A., Aizawa S., Matsuo I., Volovitch M., Prochiantz A., Hensch T.K. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity. Cell 2008, 134:508-520.
211. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002, 22:920-930.
212. Tester N.J., Howland D.R. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp Neurol 2008, 209:483-496.
213. Tom V.J., Houle J.D. Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge. Exp Neurol 2008, 211:315-319.
214. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S., Nishizaki T. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem Biophys Res Commun 2002, 294:42-45.
215. Tran M.D., Furones-Alonso O., Sanchez-Molano J., Bramlett H.M. Trauma-induced expression of astrocytic thrombospondin-1 is regulated by P2 receptors coupled to protein kinase cascades. Neuroreport 2012, 23:721-726.
216. Tropea D., Caleo M., Maffei L. Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J Neurosci 2003, 23:7034-7044.
217. van Horssen J., Kleinnijenhuis J., Maass C.N., Rensink A.A., Otte-Holler I., David G., van den Heuvel L.P., Wesseling P., de Waal R.M., Verbeek M.M. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 2002, 23:537-545.
218. van Horssen J., Wilhelmus M.M., Heljasvaara R., Pihlajaniemi T., Wesseling P., de Waal R.M., Verbeek M.M. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol 2002, 12:456-462.
219. Verbeek M.M., Otte-Holler I., van den Born J., van den Heuvel L.P., David G., Wesseling P., de Waal R.M. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol 1999, 155:2115-2125.
220. Verret L., Mann E.O., Hang G.B., Barth A.M., Cobos I., Ho K., Devidze N., Masliah E., Kreitzer A.C., Mody I., Mucke L., Palop J.J. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 2012, 149:708-721.
221. Villette V., Poindessous-Jazat F., Simon A., Lena C., Roullot E., Bellessort B., Epelbaum J., Dutar P., Stephan A. Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-beta pathology in the rat. J Neurosci 2010, 30:10991-11003.
222. Vo T., Carulli D., Ehlert E.M., Kwok J.C., Dick G., Mecollari V., Moloney E.B., Neufeld G., de Winter F., Fawcett J.W., Verhaagen J. The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain. Mol Cell Neurosci 2013, 56C:186-200.
223. Vorobyov V., Kwok J.C., Fawcett J.W., Sengpiel F. Effects of digesting chondroitin sulfate proteoglycans on plasticity in cat primary visual cortex. J Neurosci 2013, 33:234-243.
224. Wang D., Ichiyama R.M., Zhao R., Andrews M.R., Fawcett J.W. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci 2011, 31:9332-9344.
225. Ward N.S. Plasticity and the functional reorganization of the human brain. Int J Psychophysiol 2005, 58:158-161.
226. Wenk G.L. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003, 64(Suppl. 9):7-10.
227. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., Wawrzyniak M., Malinowska M., Okulski P., Kolodziej L.R., Konopka W., Duniec K., Mioduszewska B., Nikolaev E., Walczak A., Owczarek D., Gorecki D.C., Zuschratter W., Ottersen O.P., Kaczmarek L. Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 2008, 180:1021-1035.
228. Xu J., Xiao N., Xia J. Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat Neurosci 2010, 13:22-24.
229. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 1968, 243:1523-1535.
230. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000, 57:276-289.
231. Yan P., Hu X., Song H., Yin K., Bateman R.J., Cirrito J.R., Xiao Q., Hsu F.F., Turk J.W., Xu J., Hsu C.Y., Holtzman D.M., Lee J.M. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem 2006, 281:24566-24574.
232. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 2006, 26:10939-10948.
233. Yoshiyama Y., Asahina M., Hattori T. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol 2000, 99:91-95.
234. Yuan W., Matthews R.T., Sandy J.D., Gottschall P.E. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002, 114:1091-1101.
235. Zhang J.W., Deb S., Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 1998, 10:3358-3368.
236. Zhao R.R., Muir E.M., Alves J.N., Rickman H., Allan A.Y., Kwok J.C., Roet K.C., Verhaagen J., Schneider B.L., Bensadoun J.C., Ahmed S.G., Yanez-Munoz R.J., Keynes R.J., Fawcett J.W., Rogers J.H. Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons. J Neurosci Methods 2011, 201:228-238.
237. Zhou X.H., Brakebusch C., Matthies H., Oohashi T., Hirsch E., Moser M., Krug M., Seidenbecher C.I., Boeckers T.M., Rauch U., Buettner R., Gundelfinger E.D., Fassler R. Neurocan is dispensable for brain development. Mol Cell Biol 2001, 21:5970-5978.
238. Zimmermann D.R., Dours-Zimmermann M.T. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol 2008, 130:635-653.